ATE531791T1 - Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon - Google Patents

Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon

Info

Publication number
ATE531791T1
ATE531791T1 AT06808166T AT06808166T ATE531791T1 AT E531791 T1 ATE531791 T1 AT E531791T1 AT 06808166 T AT06808166 T AT 06808166T AT 06808166 T AT06808166 T AT 06808166T AT E531791 T1 ATE531791 T1 AT E531791T1
Authority
AT
Austria
Prior art keywords
cells
smooth muscular
concerns
muscular
human
Prior art date
Application number
AT06808166T
Other languages
German (de)
English (en)
Inventor
Ricousse Sophie Le
Marie-Noelle Lacassagne
Jean-Pierre Marolleau
Original Assignee
Assist Publ Hopitaux De Paris
Inst Vaisseaux Et Du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publ Hopitaux De Paris, Inst Vaisseaux Et Du Sang filed Critical Assist Publ Hopitaux De Paris
Application granted granted Critical
Publication of ATE531791T1 publication Critical patent/ATE531791T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0661—Smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT06808166T 2005-09-19 2006-09-19 Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon ATE531791T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0509557A FR2890977A1 (fr) 2005-09-19 2005-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications
PCT/FR2006/002144 WO2007034069A1 (fr) 2005-09-19 2006-09-19 Procede d'obtention de cellules musculaires lisses humaines et leurs applications

Publications (1)

Publication Number Publication Date
ATE531791T1 true ATE531791T1 (de) 2011-11-15

Family

ID=36587333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06808166T ATE531791T1 (de) 2005-09-19 2006-09-19 Verfahren zur gewinnung menschlicher glatter muskelzellen und verwendungen davon

Country Status (10)

Country Link
US (1) US20090269310A1 (enExample)
EP (1) EP1934333B9 (enExample)
JP (1) JP2009508511A (enExample)
CN (1) CN101310013B (enExample)
AT (1) ATE531791T1 (enExample)
AU (1) AU2006293814B2 (enExample)
CA (1) CA2622916A1 (enExample)
FR (1) FR2890977A1 (enExample)
IL (1) IL190289A0 (enExample)
WO (1) WO2007034069A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
KR101724639B1 (ko) * 2008-11-04 2017-04-07 리젠메드 (케이만) 엘티디. 세포-지지체 구조물
HRP20230474T1 (hr) * 2017-12-14 2023-07-21 Innovacell Ag Postupci za dobivanje stanica izvedenih iz mišića
CN112119155A (zh) * 2018-05-08 2020-12-22 苏黎士大学 用于无异种产生hMPC群的方法
EP4397752A3 (en) * 2019-03-22 2024-10-02 Innovacell GmbH Methods for obtaining induced smooth muscle cells
CN120418415A (zh) * 2022-12-28 2025-08-01 因特斯迪姆株式会社 细胞组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
US20040247575A1 (en) * 2003-06-03 2004-12-09 Caplice Noel M. Smooth muscle progenitor cells

Also Published As

Publication number Publication date
AU2006293814B2 (en) 2011-09-29
FR2890977A1 (fr) 2007-03-23
CN101310013B (zh) 2011-09-07
US20090269310A1 (en) 2009-10-29
EP1934333A1 (fr) 2008-06-25
CA2622916A1 (fr) 2007-03-29
IL190289A0 (en) 2011-08-01
CN101310013A (zh) 2008-11-19
EP1934333B1 (fr) 2011-11-02
JP2009508511A (ja) 2009-03-05
AU2006293814A1 (en) 2007-03-29
EP1934333B9 (fr) 2012-05-02
WO2007034069A1 (fr) 2007-03-29

Similar Documents

Publication Publication Date Title
EP2824175A3 (en) Mesenchymal stem cells and uses therefor
WO2007035843A3 (en) Methods and compositions for organ and tissue functionality
EP2447280A3 (en) VEGF analogs and methods of use
EP2172549A3 (en) RNAi expression constructs
EA200900177A1 (ru) Замещенные ациланилиды и способы их применения
CL2004000639A1 (es) Compuestos derivados de quinolina y quinoxalina, composicion farmaceutica, combinacion farmaceutica; kit farmaceutico; y su uso para tratar aterosclerosis, enfermedad de arteria coronaria, enfermedad cardiaca coronaria, enfermedad vascular coronaria,
EP2465921A3 (en) Cardiac stem cells from biopsy
WO2003040346A3 (en) Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
PT1404811E (pt) O monóxido de carbono melhora os resultados nos transplantes de tecidos e de orgãos e suprime a apoptose
TR201903587T4 (tr) Telomeraz aktivitesinin artırılması için bileşimler.
WO2008150490A3 (en) Uses and compositions for treatment of psoriasis and crohn's disease
WO2004047747A3 (en) Compositions and methods for cell dedifferentiation and tissue regeneration
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
IL190289A0 (en) Method for obtaining human smooth muscular cells and uses thereof
WO2004009767A3 (en) Cell therapy for regeneration
WO2008003656A3 (en) Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
WO2006081435A3 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
EA200701600A1 (ru) Способ получения лёгкодоступного клеточного материала из периферической крови и композиция на его основе
BRPI0410844A (pt) fator de crescimento de fibroblasto de codificação de plasmìdeo para o tratamento de defeitos angiogênicos associados com hipercolesterolemia ou diabetes
EP1599128A4 (en) METHOD FOR THE TREATMENT OF ILLNESSES THROUGH TRANSPLANTATION OF DEVELOPING ALLOGENIC OR XENOGENIC ORGANS OR WOVEN FABRICS
IL184849A0 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
EP1862433A4 (en) PERSONALIZED SYNTHETIC DIAMOND WITH DIFFERENT COLORS, OBTAINED FROM KERATIN (LIVING OR DEAD) HUMANS OR ANIMALS AND MANUFACTURING PROCESS THEREFOR
WO2006027693A8 (en) Tumor specific genes and variant rnas and uses thereof as targets for cancer therapy and diagnosis
WO2007016529A3 (en) Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy
WO2006093860A3 (en) Method and composition for repairing heart tissue